---
format: 
  revealjs:
    hash-type: number
    transition: fade
    auto-stretch: false
    self-contained: true
    height: 900
    width: 1600
    footer: ""
    slide-number: c/t
knitr: 
  opts_chunk: 
    echo: false

---

##  {}

::: {style="position: absolute; left: 180px; top: 200px; height: 525px; width: 1200px; background-color: #ffffff; padding: 20px; padding-left: 50px; box-shadow: 0px 15px 0px 0px #6C3483; border-radius: 5px;"}
[Leveraging real-world data and randomised controlled trials to advance personalised medicine]{style="font-size: 70px; font-weight: bold; line-height: 1em; margin: 0px"}

<br>

[Ignacio Leiva-Escobar]{style="font-size: 50px; font-weight: bold; color: #808080"} <br> 
[MSc Epidemiology - Charité Universitätsmedizin Berlin]{style="font-size: 25px;color: #808080"}  <br> 
[MSc Health Data Science - LSHTM]{style="font-size: 25px;color: #808080"} 

[2023]{style="font-size: 50px;font-weight: bold;"}
:::


## Table of Content {background-color="#581845"}
 - Background
 - Generalisability
 - Transportabilty
 - Example using:
    - Inverse probability of sampling (or selection) weighting (IPSW) 
    - Outcome model-risk prediction
    
## [Randomised Controlled Trials]{style="font-size: 70px; font-weight: bold; line-height: 1em; margin: 0px; color: #6C3483"}

\

- `RCT III` are Gold Standard for Drug approval (Efficacy) 
- Designed to generate internally valid treatment effect


  - Randomization/Masking
  

  - Monitoring and follow-up
- Included in clinical guidelines 
- Used by Health care providers

## [Trial population]{style="font-size: 70px; font-weight: bold; line-height: 1em; margin: 0px; color: #581845"}
::: columns
::: {.column width="20%"}

\ 

::: {style="position: absolute; left: 10px; top: 200px; height: 120px; width: 410px; border:0.2px solid #D9D9D9 ;background-color: #ffffff; padding: 15px; padding-left: 20px; box-shadow: -5px 0px 0px 0px #6C3483; border-radius: 5px;"}

[Random sample]{style="font-size: 35px; font-weight: bold;color: #000000"}
[$ATE_{trial\ population} = ATE_{target\ population}$]{style="font-size: 25px; font-weight: bold; color: #000000"}
:::



\ 

::: {style="position: absolute; left: 10px; top: 500px; height: 120px; width: 410px; border:0.2px solid #D9D9D9 ;background-color: #ffffff; padding: 15px; padding-left: 20px; box-shadow: -5px 0px 0px 0px #6C3483; border-radius: 5px;"}

[No random sample]{style="font-size: 35px; font-weight: bold;color: #000000"}
[$ATE_{trial\ population} \neq ATE_{target\ population}$]{style="font-size: 25px; font-weight: bold; color: #000000"}

:::

:::
::: {.column width="80%"}

![](targetpopulation.jpg){width="80%" height="80%" fig-align="center"}

:::
:::

## [External &  Internal validity ^[Raymond S. Greenberg, Medical Epidemiology, Third Edition]]{style="font-size: 67px; font-weight: bold; line-height: 1em; margin: 0px; color: #6C3483"}


::: {style="position: absolute; left: 30px; top: 200px; height: 370px; width: 600px; border:0.2px solid #D9D9D9 ;background-color: #ffffff; padding: 15px; padding-left: 20px; box-shadow: -7px 0px 0px 0px #85929e; border-radius: 5px;"}

[Internal Validity]{style="font-size: 35px; font-weight: bold;color: #000000"}

\

[“The extent to which the results of an investigation accurately reflect the situation of the study  population”]{style="font-size: 35px; font-weight: bold; color: #797474"}
:::




::: {style="position: absolute; left: 800px; top: 200px; height: 370px; width: 600px; border:0.2px solid #D9D9D9 ;background-color: #ffffff; padding: 15px; padding-left: 20px; box-shadow: -7px 0px 0px 0px #c39bd3; border-radius: 5px;"}

[External Validity]{style="font-size: 35px; font-weight: bold;color: #000000"}

\ 

[“The extent to which the results of a study are applicable to other populations”]{style="font-size: 35px; font-weight: bold; color: #797474"}

:::

## External validity can be divided into {auto-animate=true auto-animate-easing="ease-in-out"}

::: {style="position: absolute; left: 180px; top: 200px; height: 370px; width: 600px; border:0px solid #D9D9D9 ;background-color: #ffffff; padding: 0px; padding-right: 0px; box-shadow: 0px 0px 0px 0px #c39bd3; border-radius: 5px;"}



::: {.r-hstack}
::: {data-id="box1" auto-animate-delay="0" style="background: #c39bd3; width: 200px; height: 150px; margin: 10px;"}

[Target A]{style="font-size: 35px; font-weight: bold; color: #ffffff; padding-left: 35px;"}

:::

::: {data-id="box2" auto-animate-delay="0.1" style="background: #344c5c; width: 100px; height: 150px ;margin-right:-280px; "}
:::



:::
:::

::: {style="position: absolute; left: 710px; top: 200px; height: 370px; width: 600px; border:0px solid #D9D9D9 ;background-color: #ffffff; padding: 0px; padding-left: 0px; box-shadow: 0px 0px 0px 0px #c39bd3; border-radius: 5px; "}


::: {.r-hstack}

::: {data-id="box2" auto-animate-delay="0.1" style="background: #344c5c; width: 100px; height: 150px; margin-left:-280px;"}

 [Trial]{style="font-size: 35px; font-weight: bold; color: #ffffff; padding-left: 5px;"}

:::

::: {data-id="box1" auto-animate-delay="0" style="background: #85929e; width: 200px; height: 150px; margin: 10px;"}

[Target B]{style="font-size: 35px; font-weight: bold; color: #ffffff; padding-left: 35px;"}

:::


:::
:::




## External validity can be divided into {auto-animate=true auto-animate-easing="ease-in-out"}
::: {style="position: absolute; left: 200px; top: 200px; height: 370px; width: 600px; border:0px solid #D9D9D9 ;background-color: #ffffff; padding: 15px; padding-right: 0px; box-shadow: 0px 0px 0px 0px #c39bd3; border-radius: 5px; margin: 0px; float: left"}

[Generalisability]{style="font-size: 35px; font-weight: bold;color: #000000; text-align: center;padding-left: 130px;"}

\

::: {.r-stack}
::: {data-id="box1" style="background: #c39bd3; width: 350px; height: 350px; border-radius: 200px;"}
[Target A]{style="font-size: 35px; font-weight: bold; color: #ffffff; padding-left: 110px;"}
:::

::: {data-id="box2" style="background: #344c5c; width: 150px; height: 150px; border-radius: 100px;"}
[Trial]{style="font-size: 35px; font-weight: bold; color: #ffffff; padding-left: 40px;"}
:::

:::
:::
::: {style="position: absolute; left: 800px; top: 200px; height: 370px; width: 600px; border:0px solid #D9D9D9 ;background-color: #ffffff; padding: 15px; padding-left: 20px; box-shadow: 0px 0px 0px 0px #c39bd3; border-radius: 5px;"}

[Transportability]{style="font-size: 35px; font-weight: bold;color: #000000; text-align: center;padding-left: 110px;"}

\

::: {.r-hstack}
::: {data-id="box1" style="background: #85929e; width: 350px; height: 350px; border-radius: 200px;"}
[Target B]{style="font-size: 35px; font-weight: bold; color: #ffffff; padding-left: 110px;"}
:::

::: {data-id="box2" style="background: #344c5c; width: 150px; height: 150px; border-radius: 200px;left: 1200px;"}
[Trial]{style="font-size: 35px; font-weight: bold; color: #ffffff;padding-left: 40px;"}
:::


:::
:::


## How can we address this issue {auto-animate=true}

\

> [Trial design approaches]{style="font-size: 50px; font-weight: bold; line-height: 1em; margin: 0px; color: #6C3483"} 

  - Doubly randomized trials
  - Pragmatic trials
\ 

. . .

> [Analytic approaches]{style="font-size: 50px; font-weight: bold; line-height: 1em; margin: 0px; color: #6C3483"} 

  - Observational analyses / target trial emulation
  - Generalisability/transportability using trial and observational data

## [Check the]{style="font-size: 67px; font-weight: light; line-height: 1em; margin: 0px; color: #6C3483"} Identifiability conditions 

::: {style="position: absolute; left: 330px; top: 150px; height: 250px; width: 1100px; background-color: #ffffff; padding: 20px; padding-left: 50px; box-shadow: 0px 0px 7px 0px #4a235a; border-radius: 5px; border:0.2px solid #D9D9D9"}

[(I) Consistency of potential outcomes]{style="font-size: 30px; font-weight: bold; line-height: 1em; margin: 0px; color: #4a235a"}

[(II) Mean exchangeability in the trial]{style="font-size: 30px; font-weight: bold; line-height: 1em; margin: 0px; color: #4a235a"}

[(III) Positivity of treatment assignment]{style="font-size: 30px; font-weight: bold; line-height: 1em; margin: 0px; color: #4a235a"}
:::

::: {style="position: absolute; left: 20px; top: 150px; height: 250px; width: 230px; background-color: #4a235a; padding: 20px; padding-left: 50px; box-shadow: 0px 0px 7px 0px #4a235a; border-radius: 5px; border:0.2px solid #D9D9D9"}

\

[RCT]{style="font-size: 50px; font-weight: bold; line-height: 1em; margin: 0px; color: #ffffff"} 

[Internal Validity]{style="font-size: 30px; font-weight: bold; line-height: 1em; margin: 0px; color: #ffffff"} 

:::

::: {style="position: absolute; left: 330px; top: 500px; height: 250px; width: 1100px; background-color: #ffffff; padding: 20px; padding-left: 50px; box-shadow: 0px 0px 7px 0px #fab724; border-radius: 5px; border:0.2px solid #D9D9D9"}
[(IV) Conditional exchangeability for study selection* ]{style="font-size: 30px; font-weight: bold; line-height: 1em; margin: 0px; color: #D69E02"}

[(V) Positivity of trial participation*]{style="font-size: 30px; font-weight: bold; line-height: 1em; margin: 0px; color: #D69E02"}

[Additionally:]{style="font-size: 30px; font-weight: bold; line-height: 1em; margin: 0px; color: #D69E02"}
[(1) There are no unmeasured variables associated with treatment effect and trial sample selection 
(2) Well-specify model]{style="font-size: 25px; font-weight: bold; line-height: 1em; margin: 0px; color: #D69E02"}



:::


::: {style="position: absolute; left: 20px; top: 500px; height: 250px; width: 230px; background-color: #fab724; padding: 20px; padding-left: 50px; box-shadow: 0px 0px 7px 0px #fab724; border-radius: 5px; border:0.2px solid #D9D9D9"}

\

[Extend RCT]{style="font-size: 40px; font-weight: bold; line-height: 1em; margin: 0px; color: #ffffff"} 

[External Validity]{style="font-size: 30px; font-weight: bold; line-height: 1em; margin: 0px; color: #ffffff"} 

:::

## Traget population - Trial population

::: columns
::: {.column width="45%"}
![](14.jpg){width="550" height="450" fig-align="center"}
:::

::: {.column width="5%"}
<!-- empty column to create gap -->
:::

::: {.column width="45%"}
![](13.jpg){width="550" height="450" fig-align="center"}
**ATE**hdbehbdebdhbehjdbhed
:::
:::
##

::: columns
::: {.column width="45%"}
[Influenza]{style="font-size: 50px;font-weight: bold;"} 

 - Estimated 5,678,000 influenza-associated lower-respiratory tract infection (LRI) hospitalizations each year worldwide, with higher rates of hospitalization among adults over the age of 65 
 
 - In 2016, there were an estimated 5.7 million influenza-associated LRI hospitalizations globally

![](flu_hem.jpg){width="350" height="350" fig-align="center"}
:::

::: {.column width="5%"}
<!-- empty column to create gap -->
:::

::: {.column width="45%"}

[RSV]{style="font-size: 50px;font-weight: bold;"} 

 - Most common cause of respiratory-related hospitalizations in children aged less than 5 years worldwide
 
 - In 2015, there were approximately 3.2 – 5.1 million RSV-associated LRI hospital admissions globally
 
 - In France, research has shown that RSV-associated hospitalizations in children aged less than one year increased from 2010 – 2018

![](rsv_hm.jpg){width="350" height="350" fig-align="center"}

:::
:::

## Introduction of the COVID-19 pandemic

::: {style="position: absolute; centre: 480px; top: 80px; height: 250px; width: 800px; background-color: #ffffff; padding: 0px; padding-left: 50px; box-shadow: 5px 5px 5px 5px #6C3483; border-radius: 0px;"}
 - Globally, COVID-19 has accounted for more than 667 million cases and 6.7 million deaths
 - COVID-19 infections continue to peak at irregular intervals with no clear seasonality

:::

::: {.callout-note appearance="minimal"}

## RCT

`Gold Standard`

:::

## [Influenza hospitalizations from 2016 -- 19, 2022 -- 23 by country]{style="font-size: 50px"}

::: panel-tabset
#### Northern Hemisphere

```{r }
#| fig-width: 14
#| fig-height: 7.5
#| fig.align: 'center'
library(readr)
library(tidyverse)
library(ggplot2)
all_countries <- read_csv('/Users/igna/Documents/LSHTM/Term 2/Data Challenge/lshtm-dc-sanofi/data/merged_data/merged_data.csv')

seasons <- data.frame(start = c(2015:2022),
                      end = c(2016:2023),
                      seas = c("2015-16","2016-17","2017-18", "2018-19","2019-20","2020-21","2021-22","2022-23"))


all_countries$season <- NA # Create the variable

## For loop to iterate the all_countries dataset

for(i in c(seasons$start)) {
     year_start <- i
     year_end <- (seasons$end[seasons$start== i])
     p_season <- (seasons$seas[seasons$start== i])
     
     # Differentiate NH VS SH
     all_countries$season <-
     ifelse((all_countries$hemisphere == "NH" & all_countries$year == year_start & all_countries$week %in% c(40:52)) | 
                (all_countries$hemisphere == "NH" & all_countries$year == year_end & all_countries$week %in% c(1:39)), p_season,
            ifelse(
                   (all_countries$hemisphere == "SH"& all_countries$year == year_start & all_countries$week   %in% c(14:52)) |
                    (all_countries$hemisphere == "SH"& all_countries$year == year_end & all_countries$week %in% c(1:13)),p_season,all_countries$season))
            
}

# Subset varibales
subset_countries <- all_countries %>% 
     select(country, data_source, hemisphere, week, year, age_group, denominator, hsp_rate_flu, hsp_abs_flu,hsp_rate_rsv, hsp_abs_rsv, hsp_rate_covid19, hsp_abs_covid,epi_dates, season) %>% 
     filter(age_group == "ALL",data_source !='FluNet - Non Sentinel' )

# New flu considering 3% population
subset_countries$flu_rate <- ifelse(subset_countries$country == "AUS" |subset_countries$country == "FR",subset_countries$hsp_rate_flu/.03,subset_countries$hsp_rate_flu)

# New RSV considering 3% population
subset_countries$rsv_rate <- ifelse(subset_countries$country == "AUS" | subset_countries$country == "FR",subset_countries$hsp_rate_rsv/.03,subset_countries$hsp_rate_rsv)

#New COVID-19 considering 3% population
subset_countries$covid_rate <- ifelse(subset_countries$country == "AUS" | subset_countries$country == "FR",subset_countries$hsp_rate_covid19/.03, subset_countries$hsp_rate_covid19)


# Re-select 

subset_countries_final <- subset_countries %>% 
     select(country, data_source, hemisphere,epi_dates, year,week, year, season, flu_rate, rsv_rate, covid_rate)

data_graph <-  subset_countries_final %>%
     filter(season != "2015-16", hemisphere == "NH", season != "2021-22") %>% 
     #week = factor(week,levels = c(40:52,1:39) original
     mutate(week = factor(week,levels = c(31:52,1:30)),
            season = as.factor(season),
            breaks_x = as.numeric(week),
            label_x = week) 

data_graph$country[data_graph$country == "DE"] <- "GER"

axis_nh <- length(unique(data_graph$season))-1

# tried to get the mean of pre-covid season.(problem with 0 VS NA DATA)
average_data_nh <- data_graph %>% 
     filter(season == "2016-17", season == "2017-18", season == "2018-19")

## To create a thicker line
# data_graph_last_season <- data_graph %>% 
#      filter(season == "2022-23")


####  ##############################################
####  ########### INFLUENZA PLOTS NH ###############
####  ##############################################
# to make the rectangle 
db_rect <- data_graph %>% 
     group_by(country, week) %>% 
     filter(week == 40, year == 2017, country == "UK" | country =="GER"|country == "US"|country == "FR")

# Graph using face grid
plot1_flu <-  data_graph %>% 
     ggplot(aes(as.numeric(week),flu_rate, group = season, color = season)) +
     geom_line(aes(linetype = season, size = season))+#size = 0.7, linetype = 1, alpha = 0.6) +
     scale_x_continuous(breaks = data_graph$breaks_x, labels = data_graph$week, limits = c(10,42))  +
    # scale_color_manual(values=c('#999999','#E69F00', '#E69F00','#E69F00', '#E69F00')) +
     scale_linetype_manual(values=c(rep("solid", axis_nh), "twodash"))+
     scale_size_manual(values=c(rep(0.5, axis_nh), 0.7))+
     

     # create a rectangle 
     geom_rect(data = db_rect, aes(xmin = 10, xmax = 42, ymin = -Inf, ymax = Inf),color = NA, fill = '#E06666', alpha = 0.1)   +
     facet_grid(country ~ ., scales = "free_y", ) 
#facet_wrap(vars(country), scales = "free_y")

flu_nh <- plot1_flu + theme_bw() +
     theme(strip.placement = "outside",
           strip.background = element_rect(fill="grey90", color="grey50"),
           panel.spacing=unit(0.1,"cm"),
           legend.position = "bottom", 
           legend.direction = "horizontal") +
     labs(title = "Hospitalization rate for influenza, by year",
          subtitle = "Northern Hemisphere, 2016-17 through 2022–23 seasons",
          x= "Calendar week",
          y = "hospitalization (per 100,000)",
          caption = "(Epi week from 40 to 20)")

flu_nh
```

#### Southern hemispher

```{r}
#| fig-width: 14
#| fig-height: 7.5
#| fig.align: 'center'
#| 
data_graph_sh <- subset_countries %>% 
     filter(hemisphere == "SH", data_source != "AUS DOH") %>% 
     mutate(season = as.factor(year),
            breaks_x = as.numeric(week),
            label_x = week)
axis_sh <- length(unique(data_graph_sh$season))-1
db_rect_sh <- data_graph_sh %>% 
     group_by(country, week) %>% 
     filter(week == 40, year == 2017, country == "AUS" | country =="CL")

# Using facet_grid

plot1_flu_sh <-  data_graph_sh %>% 
     filter(hemisphere == "SH") %>% 
     ggplot(aes(as.numeric(week),flu_rate, group = season, color = season)) +
     geom_line(aes(linetype = season, size = season)) + #(size = 0.4, linetype = 1) +
     scale_x_continuous(breaks = data_graph_sh$breaks_x, labels = data_graph_sh$week)  +
     scale_linetype_manual(values=c(rep("solid", axis_sh), "twodash"))+
     scale_size_manual(values=c(rep(0.5, axis_sh), 0.7))+          
     
     # create a rectangle 
     geom_rect(data = db_rect_sh, aes(xmin = 16, xmax = 40, ymin = -Inf, ymax = Inf),color = NA, fill = '#E06666', alpha = 0.1)   +
     facet_grid(country ~ ., scales = "free_y", ) 
#facet_wrap(vars(country), scales = "free_y")

flu_sh <- plot1_flu_sh + theme(strip.placement = "outside",
                                  strip.background = element_rect(fill="grey90", color="grey50"),
                                  panel.spacing=unit(0.2,"cm"),
                                  legend.position = "bottom", 
                                  legend.direction = "horizontal") +
     labs(title = "Hospitalization rate for influenza, by year",
          subtitle = "Southern Hemisphere, 2016 through 2022 seasons",
          x= "Calendar week",
          y = "hospitalization (per 100,000)")

flu_sh
```
:::
